Ingredients in every tablet
Each package contains
|ATC Level 1||R - Respiratory system|
|ATC Level 2||R03 - Drugs for Obstructive Airway Diseases|
|ATC Level 3||R03D - Other Systemic Drugs for Obstructive Airway Diseases in ATC|
18 YEARS OLD AND ABOVE
The recommended dose is 1 tablet of 500 mcg, once daily.
The tablet should be swallowed with water and taken at the same time every day. The tablet can be taken with or without food. FORESPI film-coated tablets can be taken for several weeks to achieve the desired effect.
UP TO 18 YEARS
There is no relevant use of FORESPI film-coated tablet in the pediatric population (under 18 years) in the indication of COPD.
65 YEARS OLD AND ABOVE
No dosage adjustment is necessary for elderly patients (65 years and older)
No dosage adjustment is necessary for patients with renal impairment.
FORESPI film-coated tablet should be used with caution in patients with mild hepatic impairment classified as Child-Pugh A. Patients with moderate or severe hepatic impairment classified as Child-Pugh B or C must not take FORESPI film-coated tablet
Roflumilast is indicated as add-on therapy to long-acting bronchodilator(s) treatment for the maintenance of severe chronic obstructive pulmonary disease (COPD) (FEV1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in Adults patients with a history of frequent exacerbations.